pediatric psoriasis – Patient Worthy

source: pixabay.com

The European Commission Approves Cosentyx for Pediatric Psoriasis

Post author:Jessica Lynn
Post published:August 13, 2020
Post category:Psoriatic Arthritis

Following positive data from two Phase 3 trials, the European Commission (EC) approved Cosentyx (secukinumab) for the treatment of pediatric psoriasis. Drug developer Novartis announced the news early last…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More